Healthcare provider profile · identity verified

Daniel Cheng, M.D.

Internal Medicine · MUSKEGO, WI · NPI 1912970781

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	694	200
Levothyroxine Sodium	Levothyroxine Sodium	585	151
Amlodipine Besylate	Amlodipine Besylate	517	147
Omeprazole	Omeprazole	381	105
Pantoprazole Sodium	Pantoprazole Sodium	332	101
Prednisone	Prednisone	326	199
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	254	71
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	229	58
Meloxicam	Meloxicam	206	88
Alprazolam	Alprazolam	201	57
Simvastatin	Simvastatin	200	58
Diclofenac Sodium	Diclofenac Sodium	195	76
Gabapentin	Gabapentin	193	61
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	190	51
Methylprednisolone	Methylprednisolone	179	139
Lorazepam	Lorazepam	175	36
Losartan Potassium	Losartan Potassium	172	55
Rosuvastatin Calcium	Rosuvastatin Calcium	169	49
Baclofen	Baclofen	168	91
Lisinopril	Lisinopril	165	52
Metoprolol Succinate	Metoprolol Succinate	160	53
Ozempic	Semaglutide	157	27
Celecoxib	Celecoxib	155	52
Trazodone Hcl	Trazodone Hcl	155	46
Sertraline Hcl	Sertraline Hcl	153	44
Metformin Hcl Er	Metformin Hcl	146	46
Clonazepam	Clonazepam	143	25
Glipizide Er	Glipizide	143	39
Famotidine	Famotidine	140	46
Doxycycline Hyclate	Doxycycline Hyclate	135	113
Eliquis	Apixaban	128	31
Pravastatin Sodium	Pravastatin Sodium	125	38
Tamsulosin Hcl	Tamsulosin Hcl	123	40
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	120	93
Escitalopram Oxalate	Escitalopram Oxalate	116	36
Cefdinir	Cefdinir	115	96
Montelukast Sodium	Montelukast Sodium	115	34
Albuterol Sulfate Hfa	Albuterol Sulfate	111	44
Potassium Chloride	Potassium Chloride	108	36
Valsartan	Valsartan	104	30
Fluticasone Propionate	Fluticasone Propionate	103	46
Duloxetine Hcl	Duloxetine Hcl	102	26
Donepezil Hcl	Donepezil Hcl	100	17
Memantine Hcl	Memantine Hcl	99	17
Clopidogrel	Clopidogrel Bisulfate	93	27
Tramadol Hcl	Tramadol Hcl	92	28
Nifedipine Er	Nifedipine	91	25
Bupropion Xl	Bupropion Hcl	82	24
Labetalol Hcl	Labetalol Hcl	82	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	80	30
Furosemide	Furosemide	76	30
Metformin Hcl	Metformin Hcl	75	28
Zolpidem Tartrate	Zolpidem Tartrate	75	21
Doxazosin Mesylate	Doxazosin Mesylate	74	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	21
Mounjaro	Tirzepatide	73	18
Azithromycin	Azithromycin	72	53
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	25
Carvedilol	Carvedilol	70	22
Warfarin Sodium	Warfarin Sodium	69	23
Quetiapine Fumarate	Quetiapine Fumarate	68	19
Amoxicillin	Amoxicillin	67	47
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	65	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	64	45
Venlafaxine Hcl Er	Venlafaxine Hcl	64	16
Glipizide-Metformin	Glipizide/Metformin Hcl	63	20
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	62	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	59	42
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	11
Allopurinol	Allopurinol	58	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	58	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	54	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	14
Pregabalin	Pregabalin	48	15
Terbinafine Hcl	Terbinafine Hcl	48	25
Esomeprazole Magnesium	Esomeprazole Magnesium	47	13
Citalopram Hbr	Citalopram Hydrobromide	46	11
Spironolactone	Spironolactone	46	17
Fluoxetine Hcl	Fluoxetine Hcl	45	14
Aripiprazole	Aripiprazole	44	15
Bumetanide	Bumetanide	43	18
Synthroid	Levothyroxine Sodium	43	11
Alendronate Sodium	Alendronate Sodium	41	14
Cephalexin	Cephalexin	40	32
Hydrochlorothiazide	Hydrochlorothiazide	40	13
Sumatriptan Succinate	Sumatriptan Succinate	36	13
Wixela Inhub	Fluticasone Propion/Salmeterol	36	17
Clobetasol Propionate	Clobetasol Propionate	35	28
Paroxetine Hcl	Paroxetine Hcl	35	11
Metoprolol Tartrate	Metoprolol Tartrate	32	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	25
Galantamine Er	Galantamine Hbr	29	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	29	suppressed
Naproxen	Naproxen	29	17
Atenolol	Atenolol	28	suppressed
Irbesartan	Irbesartan	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	14
Hydrocortisone	Hydrocortisone	25	15
Jantoven	Warfarin Sodium	25	suppressed
Linzess	Linaclotide	25	suppressed
Ondansetron Odt	Ondansetron	25	19
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Finasteride	Finasteride	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Temazepam	Temazepam	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Topiramate	Topiramate	19	suppressed
Estradiol	Estradiol	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Carbamazepine Er	Carbamazepine	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	11
Diazepam	Diazepam	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Levofloxacin	Levofloxacin	17	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	16	suppressed
Primidone	Primidone	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Probenecid	Probenecid	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Cabergoline	Cabergoline	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	12	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error